Clinical Trials Browser

Phase 2/3 × Bevacizumab × Thoracic × Clear all

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00227617 2023-05-22

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Lung Neoplasms, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

NCT01383148 2017-01-05

TIME

Phase 2/3 Terminated

222 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00930891 2016-03-10

CPC

Phase 2/3 Completed

143 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT00021060 2013-02-27

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer

Phase 2/3 Completed

842 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

Clinical Trials

SUPER BRAIN

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

TIME

CPC

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer